education_AdobeStock_©-Robert-Kneschke_251314673_2000px_191205

Projects

EUCANCan

EUCANCan - European-Canadian Cancer Network

A federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine.

EUCANCan aims at supporting and enhancing modern oncology. The project is jointly funded by the European Union’s Horizon 2020 research and innovation programme and the Canadian Institutes of Health Research over the duration of four years.

EUCANCan focuses on implementing a cultural, technological and legal integrated framework across Europe and Canada, to enable and facilitate the efficient analysis, management and sharing of genomic oncology data. The EUCANCan community consists of different European (Germany, France, Netherlands and Spain) and Canadian healthcare and research nodes, with strong activity in genomic oncology. We (Charité/BIH and Heidelberg University Hospital) participate in several workpackages with Jürgen Eils co-leading the workpackage on “Standardized clinical reporting across sites”.

This cooperative European-Canadian framework is aimed at improving biomedical research in cancer and serving as a model for globalizing and enriching personalized medicine initiatives, allowing the exchange of data, clinical experience and information across different national health systems.

 

Further information can be found on the EUCANCan Webpage.

EUCANCan_Logo

Latest News

Martin Peuker: CIO of the year 2020

Charité CIO Martin Peuker is driving digitization in the healthcare sector with the Health Data Platform. The jury awards him 1st prize in the Public Sector category for his outstandig achievment. 

First Human Cell Atlas of the Pancreas on single-cell resolution

We are pleased to present our recent achievements in building the Human Cell Atlas of the Pancreas on single-cell resolution. Due to its high autolytic activities, the pancreas is a very challenging

Professor Dominik Niopek has been awarded the Life Science Bridge Award

Professor Dominik Niopek, Department of Biology at the TU, has been awarded the "Life Sciences Bridge - Aventis Foundation Postdoctoral Award" research prize sponsored by the Aventis Foundation. The

Computational model to reduce CRISPR-Cas9 off-target effects

We are pleased to announce our novel computational model for reducing off-target effects in CRISPR-Cas9 approaches: The manuscript Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9